Bruker Corporation Announces Closing of the Acquisition of the Bruker BioSpin Group
The former Bruker BioSciences Corporation, presently being renamed Bruker Corporation, announced that today it has closed the previously-announced acquisition of the Bruker BioSpin Group. Approximately 57.5 million new unregistered shares of BRKR common stock were issued for the stock component of the acquisition consideration. At the closing price per share of $10.86 on February 25, 2008, the stock portion of the aggregate consideration for the acquisition was approximately $624.9 million.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.